HSIC Stock Overview
Provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Narratives bring a range of perspectives from our community.
New Product Launches And Global Expansion Will Strengthen Market Presence
Henry Schein, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$69.82 |
52 Week High | US$82.63 |
52 Week Low | US$63.67 |
Beta | 0.88 |
1 Month Change | -5.30% |
3 Month Change | -1.87% |
1 Year Change | -6.81% |
3 Year Change | -6.82% |
5 Year Change | 4.87% |
Change since IPO | 1,127.60% |
Recent News & Updates
Henry Schein: The Kind Of Business I Like But No Margin Of Safety Now
Dec 10Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet?
Dec 01Henry Schein: Another Day, Another Purchase
Nov 20Recent updates
Henry Schein: The Kind Of Business I Like But No Margin Of Safety Now
Dec 10Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet?
Dec 01Henry Schein: Another Day, Another Purchase
Nov 20Henry Schein's (NASDAQ:HSIC) Conservative Accounting Might Explain Soft Earnings
Nov 13Is Now An Opportune Moment To Examine Henry Schein, Inc. (NASDAQ:HSIC)?
Nov 04Henry Schein, Inc.'s (NASDAQ:HSIC) Popularity With Investors Is Clear
Sep 27Henry Schein (NASDAQ:HSIC) Will Be Hoping To Turn Its Returns On Capital Around
Aug 20Is It Time To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?
Aug 02Market Participants Recognise Henry Schein, Inc.'s (NASDAQ:HSIC) Earnings
Jun 27Henry Schein: Acquisition Strategy Isn't Pulling Its Economic Weight
May 23Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden
May 22Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?
May 02There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital
Apr 14Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward
Feb 28Shareholder Returns
HSIC | US Healthcare | US Market | |
---|---|---|---|
7D | -8.9% | -5.0% | -3.5% |
1Y | -6.8% | -11.4% | 22.1% |
Return vs Industry: HSIC exceeded the US Healthcare industry which returned -11.4% over the past year.
Return vs Market: HSIC underperformed the US Market which returned 22.1% over the past year.
Price Volatility
HSIC volatility | |
---|---|
HSIC Average Weekly Movement | 4.2% |
Healthcare Industry Average Movement | 7.6% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 17.0% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: HSIC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: HSIC's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1932 | 26,000 | Stan Bergman | www.henryschein.com |
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.
Henry Schein, Inc. Fundamentals Summary
HSIC fundamental statistics | |
---|---|
Market cap | US$8.60b |
Earnings (TTM) | US$314.00m |
Revenue (TTM) | US$12.50b |
27.7x
P/E Ratio0.7x
P/S RatioIs HSIC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HSIC income statement (TTM) | |
---|---|
Revenue | US$12.50b |
Cost of Revenue | US$8.55b |
Gross Profit | US$3.95b |
Other Expenses | US$3.63b |
Earnings | US$314.00m |
Last Reported Earnings
Sep 28, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 2.52 |
Gross Margin | 31.59% |
Net Profit Margin | 2.51% |
Debt/Equity Ratio | 53.2% |
How did HSIC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 23:15 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/28 |
Annual Earnings | 2023/12/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Henry Schein, Inc. is covered by 38 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jeffrey Johnson | Baird |
Ishan Majumdar | Baptista Research |
Lawrence Marsh | Barclays |